Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. (Q54269757)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. |
scientific article |
Statements
Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. (English)
1 reference
James G Krueger
1 reference
Howard Sofen
1 reference
Stacy Smith
1 reference
Robert T Matheson
1 reference
Craig L Leonardi
1 reference
Cesar Calderon
1 reference
Carrie Brodmerkel
1 reference
Katherine Li
1 reference
Kim Campbell
1 reference
Stanley J Marciniak
1 reference
Yasmine Wasfi
1 reference
Yuhua Wang
1 reference
Philippe Szapary
1 reference
1 April 2014
1 reference
133
1 reference
1032-1040
1 reference
4
1 reference
Identifiers
1 reference